BLEEDING RISK ASSOCIATION IN PATIENTS WITH ASPIRIN PROPHYLAXIS FOR PRE-ECLAMPSIA

Simple item page
dc.contributor.authorOrtega Martín del Campo Eduardo
dc.contributor.authorHernández Paniagua José Eduardo
dc.contributor.authorNieto Vázquez Eduardo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T18:47:40Z
dc.date.available2026-03-22T18:47:40Z
dc.date.issued2022
dc.description.abstractPreeclampsia is characterized by arterial hypertension in the pregnant patient that can condition the affection to a target organ. It is considered one of the main causes of morbi maternal-fetal mortality, affecting approximately between 3 to 8% of pregnancies at the world. Due to its relevance, there are currently screening and risk assessment methods to know if a patient can present this pathology. (1) Currently aspirin is a drug used worldwide for its anti-inammatory and antiaggregant activity platelet, so since the 70's its consumption was proposed as a method of prevention for preeclampsia. (2).
dc.identifier.doi10.36106/gjra/7210175
dc.identifier.urihttps://doi.org/10.36106/gjra/7210175
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/72230
dc.language.isoen
dc.relation.ispartofGLOBAL JOURNAL FOR RESEARCH ANALYSIS
dc.sourceUniversidad La Salle
dc.subjectAspirin
dc.subjectMedicine
dc.subjectEclampsia
dc.subjectPreeclampsia
dc.subjectPregnancy
dc.subjectObstetrics
dc.subjectIntensive care medicine
dc.titleBLEEDING RISK ASSOCIATION IN PATIENTS WITH ASPIRIN PROPHYLAXIS FOR PRE-ECLAMPSIA
dc.typearticle

Files

Collections

Artículo Científico Publicado